Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-02-21 @ 1:16 PM
Study NCT ID:
NCT03611556
Status:
COMPLETED
Last Update Posted:
2023-10-03
First Post:
2018-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D6070C00005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None